Literature DB >> 25572764

The metabolic syndrome in type 2 diabetic patients in Gorgan: According to NCEP ATPIII and IDF definitions.

Abdoljalal Marjani1, Ahmad Shirafkan2.   

Abstract

AIMS: People with metabolic syndrome are at increased risk for developing diabetes mellitus and cardiovascular disease. The present study aimed to assess the metabolic syndrome in type 2 diabetes and compare them with two used methods of diagnostic criteria in Gorgan.
METHODS: The study group included 293 type 2 diabetic patients whom referred to the Department of Diabetes Center in Golestan University of Medical Sciences (2011). The metabolic syndrome was determined according to ATPIII and IDF definitions.
RESULTS: According to ATPIII and IDF criteria, the frequency of metabolic syndrome was 75.42% and 76.79%, respectively. According to ATPIII, the mean triglycerides, body mass index, systolic blood pressure and diastolic blood pressure were higher in subjects with metabolic syndrome than subjects without metabolic syndrome. According to IDF, the mean triglycerides, body mass index and males' waist circumferences were higher in subjects with metabolic syndrome.
CONCLUSIONS: This study showed that females were more affected than males. This may be due to the specific characteristics in the lifestyle changes between females and males diabetic patients among Gorgan inhabitants. Females are less educated in comparison with males diabetic. The majority of females with metabolic syndrome were householder. It seems that they do less physical activity at home. In conclusion, it appears that the female need to change their life style in this area to halt the burden of cardiovascular complications in diabetic patients.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 25572764     DOI: 10.1016/j.dsx.2012.02.009

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  3 in total

1.  Prevalence of dyslipidemia and hypertension in Indian type 2 diabetic patients with metabolic syndrome and its clinical significance.

Authors:  Dhananjay Yadav; Meerambika Mishra; Arvind Tiwari; Prakash Singh Bisen; Hari Mohan Goswamy; G B K S Prasad
Journal:  Osong Public Health Res Perspect       Date:  2014-05-09

Review 2.  Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.

Authors:  Lei Peng; Yu Chen; Shaoqing Shi; Heling Wen
Journal:  Stem Cell Res Ther       Date:  2022-01-24       Impact factor: 6.832

3.  Exosomal microRNA-16-5p from human urine-derived stem cells ameliorates diabetic nephropathy through protection of podocyte.

Authors:  Yu-Rui Duan; Bao-Ping Chen; Fang Chen; Su-Xia Yang; Chao-Yang Zhu; Ya-Li Ma; Yang Li; Jun Shi
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.